Life Sciences
BridgeBio to Present Phase 3 Encaleret Data at Boston Bone Meeting
The company's results in autosomal dominant hypocalcemia type 1 are scheduled for two oral presentations on October 11 at the Boston gathering.
Elena Marchetti
Biotech & Life Sciences
Elena covers Greater Boston’s life sciences industry, from Kendall Square startups to the lab space market in the Seaport and suburbs. She reports on funding rounds, layoffs, clinical milestones and the real estate built around the sector. She lives in Somerville.
Brigham Nurses, Management Set Talks Before Oct. 14 Strike
At Least 442 Mass. Biotech Jobs Cut In Third Quarter
Boston Biotech Rezera Says Its Pill Boosts Semaglutide's Anti-Inflammatory Effect
BD Marks 65 Years In Canaan, Pours $34M Into Syringe Plant
Encompass Health Opens 50-Bed Rehab Hospital In Bangor
